African Swine Fever Virus Immunotherapies and Vaccine Development
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 1 March 2026 | Viewed by 257
Special Issue Editors
Interests: swine virus infection; immune; immunotherapy
Interests: virus infection; cell biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We invite you to contribute to a Special Issue titled "African Swine Fever Virus Immunotherapies and Vaccine Development", which will focus on the latest advancements and challenges in combating the African Swine Fever Virus (ASFV) through immunotherapies and vaccine development.
ASFV affects both domestic pigs and wild boars, resulting in a significant economic impact on the global swine industry. Currently, there are no safe and effective vaccines or treatments for ASFV. Recent outbreaks have renewed the urgency to develop effective immunotherapies and vaccines to prevent and control ASFV. This Special Issue discusses recent advancements, innovative strategies, and ongoing research in ASFV immunology, vaccine development, and therapeutic interventions.
Specifically, it will explore the immunological mechanisms involved in ASFV infection, candidate vaccines, therapeutic strategies, and diagnostic tools.
We encourage submissions that address both the fundamental and applied aspects of ASFV immunology, offering new insights into potential solutions for combating this disease. We welcome original research articles and reviews in this Special Issue.
Typical research areas may include:
- Immunology and vaccine development;
- ASFV pathogenesis and immune evasion;
- Vaccine candidates and development of vaccine strategies;
- Diagnostics and technologies for ASFV;
- Challenges and future directions in ASFV vaccine development.
We look forward to receiving your contributions.
Prof. Dr. Tao Feng
Dr. Xiaodong Qin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ASFV
- vaccine development
- pathogenesis
- immune evasion
- diagnostic tools and technologies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
